We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 41-44 of 44 Articles
Medical News & Perspectives | 
Mike Mitka
JAMA. 1998;280(1):9-10. doi:10.1001/jama.280.1.9-JMN0701-3-1.

Quick Uptakes | 
Rebecca Voelker
JAMA. 1998;279(20):1599. doi:10.1001/jama.279.20.1599-JQU80002-2-1.

Original Contribution |  FREE
William J. Catalona, MD; Alan W. Partin, MD, PhD; Kevin M. Slawin, MD; et al.
JAMA. 1998;279(19):1542-1547. doi:10.1001/jama.279.19.1542.

Medical News & Perspectives | 
Phil Gunby
JAMA. 1998;279(13):982-983. doi:10.1001/jama.279.13.982-JMN0401-3-1.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
PD-L1 Expression as a Predictive Biomarker Is Absence of Proof the Same as Proof of Absence?
Feriyl Bhaijee, MD; Robert A. Anders, MD, PhD
JAMA Oncology
Viewpoint  | 
PD-L1 Testing in Cancer Challenges in Companion Diagnostic Development
Aaron R. Hansen, MBBS (Hons), FRACP; Lillian L. Siu, MD
JAMA Dermatology
Original Investigation  | 
The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma
Rui Xu, BS; Mu-Yan Cai, MD; Rong-Zhen Luo, MD; et al.
JAMA Oncology
Original Investigation  | 
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.